NYLI MacKay中期市政债券主动型ETF MMIT 深 沪
等待开盘 03-26 09:30:00 美东时间
24.13
0.000
0.00%
华盛通- 最 高24.19
- 今 开24.19
- 成交量 25.62万股
- 最 低 24.10
- 昨 收 24.13
- 总市值 14.26亿
- 52周最高 24.7032
- 市盈率 静 --
- 换手率 0.43%
- 52周最低 22.2013
- 委 比 -33.33%
- 总股本 5910.00万
- 历史最高 24.7032
- 量 比 0.97
- 振 幅 0.37%
- 历史最低 17.7186
- 每 手 1
- 风险率 0.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Mobius Investment Trust to Publish February 2026 Monthly Factsheet
Mobius Investment Trust Plc ( ($GB:MMIT) ) has shared an update. Mobius Investm...
03-20 23:47
BRIEF-Japan, U.S. To Agree On Joint Development Of Rare Earth Elements, Lithium, Copper At Summit Meeting This Week, Nikkei Says
BRIEF-Japan, U.S. To Agree On Joint Development Of Rare Earth Elements, Lithium, Copper At Summit Meeting This Week, Nikkei Says March 17 (Reuters) - Mitsubishi Materials Corp 5711.T : JAPAN, U.S. TO AGREE ON JOINT DEVELOPMENT OF RARE EARTH ELEMENTS, LITHIUM, COPPER AT SUMMIT MEETING THIS WEEK, NIKK
03-17 17:14
Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application
FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 2026. COGT stock rises on the news.
03-17 00:42
BRIEF-Summit Royalties Announces Agreement to Acquire Royalty on Newmont's Saddle North Deposit
BRIEF-Summit Royalties Announces Agreement to Acquire Royalty on Newmont's Saddle North Deposit March 12 (Reuters) - Summit Royalties Ltd SUM.V : SUMMIT ROYALTIES ANNOUNCES AGREEMENT TO ACQUIRE ROYALTY ON NEWMONT'S SADDLE NORTH DEPOSIT SUMMIT ROYALTIES LTD - TO BUY 1.0% NSR ROYALTY ON SADDLE NORTH F
03-12 18:25
Reported Saturday, Cogent Biosciences Highlights SUMMIT Data At AAAAI 2026, Bezuclastinib Delivers –32.0 Point Mean TSS Reduction At 48 Weeks With 99% Achieving ≥50% Serum Tryptase Reduction
Bezuclastinib mean TSS reduction deepens to –32.0 points at 48 weeks of treatment with further improvement shown across all measured symptoms99% of patients achieve >50% reduction in serum tryptase at 48 weeks, with
03-02 15:51
Mobius Investment Trust publishes January 2026 monthly factsheet
Mobius Investment Trust Plc ( ($GB:MMIT) ) has issued an update. Mobius Investm...
02-18 18:32
SL Green Realty Corp full-year 2025 net income attributable to shareholders at USD -111.86 million, down from prior year
SL Green Realty Corp full-year 2025 net income attributable to shareholders at USD -111.86 million, down from prior year SL Green Realty Corporation reported a net loss attributable to common stockholders of USD 111.86 million for the full year 2025. Funds from Operations (FFO) attributable to commo
02-18 06:28
Cogent Biosciences Q4 net loss widens
Cogent Biosciences Q4 net loss widens Overview Biotech firm reported Q4 2025 net loss of $102.5 mln, increased from last year Company maintains strong cash position with $901 mln, funding operations into 2028 Bezuclastinib NDA submissions on track for 2026, including AdvSM and GIST indications Outlo
02-17 21:07
Cogent Biosciences Unveils Positive SUMMIT Trial Results for Bezuclastinib in Nonadvanced Systemic Mastocytosis
Cogent Biosciences Unveils Positive SUMMIT Trial Results for Bezuclastinib in Nonadvanced Systemic Mastocytosis Cogent Biosciences Inc. has announced multiple upcoming poster presentations featuring results from the SUMMIT trial evaluating bezuclastinib in adults with nonadvanced systemic mastocytos
02-10 21:04
Cogent Biosciences stellt neue Bezuclastinib-Studienergebnisse bei systemischer Mastozytose vor
Cogent Biosciences stellt neue Bezuclastinib-Studienergebnisse bei systemischer Mastozytose vor Cogent Biosciences Inc. hat angekündigt, dass auf der AAAAI-Jahrestagung 2026 in Philadelphia mehrere Posterpräsentationen mit Ergebnissen der Phase-2-Studie SUMMIT zu Bezuclastinib bei Erwachsenen mit ni
02-10 21:04
